Tygh Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$3.41M Buy
84,782
+538
+0.6% +$20.1K 0.44% 72
2021
Q3
$3.43M Buy
84,244
+9,419
+13% +$394K 0.46% 77
2021
Q2
$3.4M Sell
74,825
-748
-1% -$33.1K 0.46% 77
2021
Q1
$3.15M Buy
75,573
+2,913
+4% +$133K 0.45% 78
2020
Q4
$3.1M Buy
72,660
+356
+0.5% +$12.8K 0.48% 78
2020
Q3
$1.9M Buy
+72,304
New +$2.01M 0.36% 78

Other funds holding HALO

Tygh Capital Management's HALO Position: Q4 2021 in Review

Tygh Capital Management increased its Halozyme (HALO) stake by 0.64% in Q4 2021, buying an estimated $20.1K and bringing the position to 84,782 shares worth $3.41M. The position accounts for 0.44% of the portfolio, ranked #72.

Tygh Capital Management first reported a position in HALO in Q3 2020 and has held it in 6 quarters since. The position peaked at $3.43M in Q3 2021. 325 funds tracked by Wall St. Rank hold HALO as of Q4 2021.

  • Tygh Capital Management held 84,782 shares of Halozyme worth $3.41M as of Q4 2021.
  • Tygh Capital Management bought 538 Halozyme shares in Q4 2021, an estimated $20.1K.
  • Halozyme made up 0.44% of Tygh Capital Management's portfolio in Q4 2021, its #72 holding.
  • Tygh Capital Management first reported a position in Halozyme in Q3 2020 and has held it in 6 quarters since.
  • Tygh Capital Management's Halozyme position peaked at $3.43M in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Halozyme as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.